Gene · 1874
Papers2,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of both transcription and RNA turnover contribute to germline specification. | Nucleic Acids Res | 2022 | 35776114 | PubTator, text mining | PubMed |
| Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts. | BMC Pediatr | 2022 | 35764946 | PubTator, text mining | PubMed |
| Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy. | Cancer Immunol Res | 2022 | 35759797 | PubTator, text mining | PubMed |
| Differential gene expression orchestrated by transcription factors in osteoporosis: bioinformatics analysis of associated polymorphism elaborating functional relationships. | Aging (Albany NY) | 2022 | 35748775 | PubTator, text mining | PubMed |
| The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy. | J Pers Med | 2022 | 35743687 | PubTator, text mining | PubMed |
| Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method. | Int J Mol Sci | 2022 | 35743172 | PubTator, text mining | PubMed |
| Discovery and Functional Characterization of Two Regulatory Variants Underlying Lupus Susceptibility at 2p13.1. | Genes (Basel) | 2022 | 35741778 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities. | Biomedicines | 2022 | 35740349 | PubTator, text mining | PubMed |
| The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis. | Antioxidants (Basel) | 2022 | 35740092 | PubTator, text mining | PubMed |
| Tumor Suppressive Effects of GAS5 in Cancer Cells. | Noncoding RNA | 2022 | 35736636 | PubTator, text mining | PubMed |
| PUMILIO competes with AUF1 to control DICER1 RNA levels and miRNA processing. | Nucleic Acids Res | 2022 | 35736218 | PubTator, text mining | PubMed |
| CLP1 is a Prognosis-Related Biomarker and Correlates With Immune Infiltrates in Rheumatoid Arthritis. | Front Pharmacol | 2022 | 35721104 | PubTator, text mining | PubMed |
| Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family. | Structure | 2022 | 35716663 | PubTator, text mining | PubMed |
| Comparative parallel multi-omics analysis during the induction of pluripotent and trophectoderm states. | Nat Commun | 2022 | 35715410 | PubTator, text mining | PubMed |
| Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells. | J Clin Invest | 2022 | 35700053 | PubTator, text mining | PubMed |
| Systematic lncRNA mapping to genome-wide co-essential modules uncovers cancer dependency on uncharacterized lncRNAs. | Elife | 2022 | 35695878 | PubTator, text mining | PubMed |
| Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods. | Pathol Oncol Res | 2022 | 35693634 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer. | Pathol Oncol Res | 2022 | 35685866 | PubTator, text mining | PubMed |
| APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis? | Annu Rev Virol | 2022 | 35671565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1874/papers?page=20